31st Jul 2006 17:03
Imperial Innovations Group plc31 July 2006 Imperial Innovations Group plc (the "Company") The Company announces the following share dealings by directors/directors'family: 1. As set out in the Company's Prospectus approved by the FinancialServices Authority and published on 20 July 2006, upon Admission of all of theCompany's ordinary shares of 3 1/33 pence each (each an "Ordinary Share") totrading on the AIM Market of London Stock Exchange plc (which occurred today)all of the then issued B ordinary shares of 1 penny each in the capital of theCompany ("B Ordinary Shares") converted into Ordinary Shares. Conversion waseffected in accordance with the then existing articles of association of theCompany and the number of Ordinary Shares arising on conversion of all of the BOrdinary Shares upon Admission was 1,181,391 Ordinary Shares (for nilconsideration). Certain directors of the Company were entitled to OrdinaryShares pursuant to this conversion of B Ordinary Shares into Ordinary Shares, asfollows: • Dr. Martin Knight's 15,000 B Ordinary Shares converted into 118,140 Ordinary Shares (which represents approximately 0.24 per cent. of the Company's issued share capital); • Susan Searle's 15,000 B Ordinary Shares converted into 118,140 Ordinary Shares (which represents approximately 0.24 per cent. of the Company's issued share capital); and • Julian Smith's 10,000 B Ordinary Shares converted into 78,760 Ordinary Shares (which represents approximately 0.16 per cent. of the Company's issued share capital). 2. Dr. Tidu Maini, a director of the Company, has (through a nominee)bought and been allotted 2,740 Ordinary Shares at the offer price of £3.65 perOrdinary Share (the "Offer Price") pursuant to the Company's recent public offer(the "Public Offer"). Dr. Maini's wife has also (through a nominee) bought andbeen allotted 2,740 Ordinary Shares pursuant to the Public Offer. The aggregatenumber of Ordinary Shares held by Dr. Tidu Maini and his wife represents 0.01per cent. of the Company's issued share capital. Name of contact and telephone number for queries: Justin Bowen - 020 7594 6593 31 July, 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Imperial Innovations Group